The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Characterizing the Target of Acute Stroke Therapy
Abstract
Background The development of effective therapies for acute ischemic stroke presumes the existence of potentially salvageable ischemic tissue when therapy is initiated because it is widely assumed that the effectiveness of most acute stroke therapies under development is related to reducing ultimate infarct size to promote functional improvement. Such salvageable ischemic tissue was previously labeled the ischemic penumbra and must be distinguished from irreversible injury. Summary of Review Pathological identification of irreversibility (infarction) appears to lag behind the actual development of this condition, and reversible injury after focal ischemia should be differentiated from infarction. Imaging and biochemical markers apparently can provide clues for distinguishing potentially salvageable from irreversibly injured ischemic tissue in experimental and clinical stroke. Recent positron emission tomography and MRI studies suggest that these clinically available imaging technologies will be useful for determining the presence of ischemic penumbra in individual stroke patients. The progression from potentially reversible to irreversible injury after focal brain ischemia has many potential mechanisms that may be synergistic and vary among individuals. Conclusions Delineating and prioritizing these mechanisms provides the opportunity to develop multiple potential acute stroke therapies that ultimately will be used in combination, perhaps directed by imaging technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Thresholds in cerebral ischemia - the ischemic penumbra.
Astrup, J., Siesjö, B. K., & Symon, L. (1981) · Stroke · doi:10.1161/01.str.12.6.723 · Cited by 2,820
Viability thresholds and the penumbra of focal ischemia
Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370
Cited by
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
Kidwell, C. S., Jahan, R., Gornbein, J., Alger, J. R., Nenov, V., Ajani, Z., Feng, L., Meyer, B. C., Olson, S., Schwamm, L. H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212793 · Cited by 1,387
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
Kidwell, C. S., Saver, J. L., Mattiello, J., Starkman, S., Vinuela, F., Duckwiler, G., Gobin, Y. P., Jahan, R., Vespa, P., Kalafut, M., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<462::aid-ana9>3.0.co;2-y · Cited by 692
Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction
(2003) · Cerebrovascular Diseases · doi:10.1159/000069318 · Cited by 660
Measuring Cerebral Blood Flow Using Magnetic Resonance Imaging Techniques
Calamante, F., Thomas, D. L., Pell, G. S., Wiersma, J., & Turner, R. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00001 · Cited by 638
Gladstone, D. J., Black, S. E., & Hakim, A. M. (2002) · Stroke · doi:10.1161/01.str.0000025518.34157.51 · Cited by 635
Magnetic Resonance Imaging of Acute Stroke
Baird, A. E., & Warach, S. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199806000-00001 · Cited by 545
The role of diffusion tensor imaging in the evaluation of ischemic brain injury – a review
Sotak, C. H. (2002) · NMR in Biomedicine · doi:10.1002/nbm.786 · Cited by 433
Schwamm, L. H., Koroshetz, W. J., Sorensen, A. G., Wang, B., Copen, W. A., Budzik, R., Rordorf, G., Buonanno, F. S., Schaefer, P. W., & Gonzalez, R. G. (1998) · Stroke · doi:10.1161/01.str.29.11.2268 · Cited by 370
Ischemic Penumbra: Evidence From Functional Imaging in Man
Heiss, W.-D. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200009000-00002 · Cited by 367
Latchaw, R. E., Yonas, H., Hunter, G. J., Yuh, W. T. C., Ueda, T., Sorensen, A. G., Sunshine, J. L., Biller, J., Wechsler, L., Higashida, R., et al. (2003) · Stroke · doi:10.1161/01.str.0000064840.99271.9e · Cited by 319
Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans
Fiehler, J., Foth, M., Kucinski, T., Knab, R., von Bezold, M., Weiller, C., Zeumer, H., & Röther, J. (2002) · Stroke · doi:10.1161/hs0102.100884 · Cited by 286
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
Self-citationEarly recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI
Jansen, O., Schellinger, P., Fiebach, J., Hacke, W., & Sartor, K. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01146-0 · Cited by 258
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
Self-citation
Metadata
- Authors
- Fisher, M.
- Venue
- Stroke
- Published
- 1997-04
- Volume
- 28
- Issue
- 4
- Pages
- 866-872
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2108578526
- Cited by
- 201
- References
- 3
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.